Elliot Israel, MD

Quick facts

Marketed products

• Prasugrel Oral Tablet · Cardiovascular
  Prasugrel is a thienopyridine antiplatelet agent that irreversibly inhibits the P2Y12 adenosine diphosphate receptor on platelets, preventing platelet aggregation and thrombosis.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Elliot Israel, MD portfolio CI brief
• Elliot Israel, MD pipeline updates RSS